CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Oct. 31, 2020	Jul. 31, 2020
Current assets
Cash	$ 500,668	$ 18,281
Investment securities	16,518	10,436
Other prepaid expenses and current assets	21,612	2,945
Total current assets	538,798	31,662
Intellectual property	300	300
Project development costs, including $28,236 and $51,500 to related parties, at October 31, 2020 and July 31, 2020, respectively	886,684	134,413
Total assets	1,425,782	166,375
Current liabilities
Accounts payable and accrued expenses	67,197	170,972
Compensation and related expenses payable, including $90,000 and $90,000 to a related party, at October 31, 2020 and July 31, 2020, respectively	207,427	120,317
Unsecured promissory note payable to related party, including accrued interest payable of $56 at October 31, 2020	100,056
Convertible promissory note payable, including accrued interest payable of $427, at July 31, 2020		25,427
Total current liabilities	374,680	316,716
Non-current liabilities:
Secured multiple advance promissory note payable to related party, including accrued interest payable of $3,236 at October 31, 2020	803,236
Convertible promissory note payable, including accrued interest payable of $616 at October 31, 2020	100,616
Total liabilities	1,278,532	316,716
Stockholders' deficiency:
Preferred Stock, $0.0001 par value; authorized - 20,000,000 shares; issued and outstanding - 1,434 shares; Series B preferred stock, $0.0001 par value; authorized - 2,000,000 shares; issued and outstanding - 1,347 shares	202	202
Common stock, $0.0001 par value; authorized - 200,000,000 shares; issued and outstanding - 110,020,171 shares and 96,691,761 shares at October 31, 2020 and July 31, 2020, respectively	11,002	9,669
Additional paid-in capital	2,163,232	1,456,644
Common stock subscription receivable, related party	(482,600)	(550,000)
Accumulated deficit	(1,544,658)	(1,066,928)
Total members' equity	147,250	(150,341)
Total liabilities and members' equity	1,425,782	166,375
Series B Preferred Stock
Stockholders' deficiency:
Preferred Stock, $0.0001 par value; authorized - 20,000,000 shares; issued and outstanding - 1,434 shares; Series B preferred stock, $0.0001 par value; authorized - 2,000,000 shares; issued and outstanding - 1,347 shares	$ 72	$ 72